Walleye Capital LLC Celldex Therapeutics, Inc. Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $1.61 Million - $2.09 Million	49,147 Added 4743.92%	50,183 $1.86 Million
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $5.93 Million - $8.73 Million	-168,232 Reduced 99.39%	1,036 $43,000
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $232,317 - $417,678	10,275 Added 6.46%	169,268 $6.71 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $960,508 - $1.41 Million	37,741 Added 31.13%	158,993 $4.38 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $1.56 Million - $1.97 Million	51,436 Added 73.67%	121,252 $4.11 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $537,559 - $733,078	-15,456 Reduced 18.13%	69,816 $2.51 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $2.41 Million - $3.93 Million	-86,630 Reduced 50.39%	85,272 $3.8 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $3.9 Million - $6.46 Million	171,902 New	171,902 $4.83 Million
Q2 2022 Aug 08, 2022	SELL	$20.5 - $37.33 $766,310 - $1.4 Million	-37,381 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $639,976 - $910,415	23,154 Added 162.75%	37,381 $1.27 Million
Q4 2021 Mar 03, 2022	BUY	$35.68 - $56.27 $507,619 - $800,553	14,227 New	14,227 $549,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.